Sunshine Biopharma (SBFM) Competitors $1.29 +0.04 (+3.20%) Closing price 04/21/2025 04:00 PM EasternExtended Trading$1.23 -0.06 (-5.04%) As of 05:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SBFM vs. GNPX, LIPO, AYTU, APLM, GTBP, CDT, FRTX, CANF, NKGN, and RNAZShould you be buying Sunshine Biopharma stock or one of its competitors? The main competitors of Sunshine Biopharma include Genprex (GNPX), Lipella Pharmaceuticals (LIPO), Aytu BioPharma (AYTU), Apollomics (APLM), GT Biopharma (GTBP), Conduit Pharmaceuticals (CDT), Fresh Tracks Therapeutics (FRTX), Can-Fite BioPharma (CANF), NKGen Biotech (NKGN), and TransCode Therapeutics (RNAZ). These companies are all part of the "pharmaceutical products" industry. Sunshine Biopharma vs. Genprex Lipella Pharmaceuticals Aytu BioPharma Apollomics GT Biopharma Conduit Pharmaceuticals Fresh Tracks Therapeutics Can-Fite BioPharma NKGen Biotech TransCode Therapeutics Genprex (NASDAQ:GNPX) and Sunshine Biopharma (NASDAQ:SBFM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations. Which has more volatility & risk, GNPX or SBFM? Genprex has a beta of -0.4, suggesting that its stock price is 140% less volatile than the S&P 500. Comparatively, Sunshine Biopharma has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Does the MarketBeat Community favor GNPX or SBFM? Genprex received 197 more outperform votes than Sunshine Biopharma when rated by MarketBeat users. However, 100.00% of users gave Sunshine Biopharma an outperform vote while only 65.25% of users gave Genprex an outperform vote. CompanyUnderperformOutperformGenprexOutperform Votes19965.25% Underperform Votes10634.75% Sunshine BiopharmaOutperform Votes2100.00% Underperform VotesNo Votes Do analysts prefer GNPX or SBFM? Genprex presently has a consensus target price of $10.00, indicating a potential upside of 4,342.47%. Sunshine Biopharma has a consensus target price of $15.00, indicating a potential upside of 1,062.79%. Given Genprex's higher possible upside, analysts clearly believe Genprex is more favorable than Sunshine Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genprex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sunshine Biopharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is GNPX or SBFM more profitable? Genprex has a net margin of 0.00% compared to Sunshine Biopharma's net margin of -12.82%. Sunshine Biopharma's return on equity of -17.89% beat Genprex's return on equity.Company Net Margins Return on Equity Return on Assets GenprexN/A -409.48% -269.17% Sunshine Biopharma -12.82%-17.89%-14.25% Which has preferable earnings & valuation, GNPX or SBFM? Sunshine Biopharma has higher revenue and earnings than Genprex. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenprexN/AN/A-$30.86MN/AN/ASunshine Biopharma$34.87M0.10-$4.51M-$150.88-0.01 Does the media favor GNPX or SBFM? In the previous week, Genprex and Genprex both had 1 articles in the media. Genprex's average media sentiment score of 0.99 beat Sunshine Biopharma's score of 0.00 indicating that Genprex is being referred to more favorably in the media. Company Overall Sentiment Genprex Positive Sunshine Biopharma Neutral Do institutionals & insiders have more ownership in GNPX or SBFM? 14.1% of Genprex shares are held by institutional investors. Comparatively, 42.0% of Sunshine Biopharma shares are held by institutional investors. 8.5% of Genprex shares are held by company insiders. Comparatively, 0.1% of Sunshine Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummarySunshine Biopharma beats Genprex on 7 of the 12 factors compared between the two stocks. Get Sunshine Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SBFM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBFM vs. The Competition Export to ExcelMetricSunshine BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.49M$6.40B$5.25B$7.15BDividend YieldN/A3.21%5.44%4.34%P/E Ratio-0.016.7921.5917.51Price / Sales0.10234.14378.8396.22Price / CashN/A65.6738.2034.62Price / Book0.005.946.483.91Net Income-$4.51M$142.23M$3.20B$247.19M7 Day Performance0.78%0.37%-0.22%-0.19%1 Month Performance-43.42%-13.19%-10.07%-8.18%1 Year Performance-10.42%-7.93%11.95%-1.32% Sunshine Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBFMSunshine Biopharma1.8849 of 5 stars$1.29+3.2%$15.00+1,062.8%-26.9%$3.49M$34.87M-0.013Short Interest ↑Gap UpHigh Trading VolumeGNPXGenprex4.3795 of 5 stars$0.26-0.8%$10.00+3,680.7%-89.4%$6.39MN/A0.0020Short Interest ↓Positive NewsLIPOLipella Pharmaceuticals1.3877 of 5 stars$2.45+0.4%N/A-60.3%$6.25M$536,357.00-0.584News CoverageGap DownAYTUAytu BioPharma0.848 of 5 stars$1.00-3.7%N/A-63.1%$6.17M$77.23M-0.69160News CoverageAPLMApollomics1.6901 of 5 stars$5.63-5.4%$200.00+3,452.4%-87.5%$6.12M$1.22M0.0045Positive NewsGap UpGTBPGT Biopharma3.427 of 5 stars$2.29+2.7%$11.00+380.3%-41.2%$5.81MN/A-0.338Short Interest ↓Positive NewsGap UpCDTConduit Pharmaceuticals0.225 of 5 stars$0.87-4.6%N/A-99.8%$5.78MN/A-0.023Gap UpFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+3.9%$5.59M$10.06M-0.6620CANFCan-Fite BioPharma2.1277 of 5 stars$1.30-17.2%$14.00+976.9%-37.4%$5.56M$667,000.00-0.738Gap UpHigh Trading VolumeNKGNNKGen BiotechN/A$0.12+4.3%N/A-87.8%$5.40M$80,000.00-0.02N/AGap UpRNAZTransCode Therapeutics1.8769 of 5 stars$0.41+1.5%$20.00+4,778.0%-99.9%$5.37MN/A0.009 Related Companies and Tools Related Companies GNPX Competitors LIPO Competitors AYTU Competitors APLM Competitors GTBP Competitors CDT Competitors FRTX Competitors CANF Competitors NKGN Competitors RNAZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBFM) was last updated on 4/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredBiggest AI gains still ahead…? (Major announcement coming)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrade War Just Turned 3 Unknown Stocks Into Rocket FuelThe Real Catalyst Behind America’s Next Bull Run One overlooked sector is being completely repriced — and s...Insiders Exposed | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBFM Stock Free SBFM Stock Alerts